1768 related articles for article (PubMed ID: 18471545)
41. Hepatic fibrogenesis.
Valkova M
Bratisl Lek Listy; 2002; 103(2):76-85. PubMed ID: 12061025
[TBL] [Abstract][Full Text] [Related]
42. The immunology of fibrogenesis in alcoholic liver disease.
Chedid A; Arain S; Snyder A; Mathurin P; Capron F; Naveau S
Arch Pathol Lab Med; 2004 Nov; 128(11):1230-8. PubMed ID: 15504057
[TBL] [Abstract][Full Text] [Related]
43. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
Friedman SL
Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
[TBL] [Abstract][Full Text] [Related]
44. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
45. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
46. Genesis of hepatic fibrosis and its biochemical markers.
Das SK; Vasudevan DM
Scand J Clin Lab Invest; 2008; 68(4):260-9. PubMed ID: 18609066
[TBL] [Abstract][Full Text] [Related]
47. Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells.
Novo E; Busletta C; Bonzo LV; Povero D; Paternostro C; Mareschi K; Ferrero I; David E; Bertolani C; Caligiuri A; Cannito S; Tamagno E; Compagnone A; Colombatto S; Marra F; Fagioli F; Pinzani M; Parola M
J Hepatol; 2011 May; 54(5):964-74. PubMed ID: 21145826
[TBL] [Abstract][Full Text] [Related]
48. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis.
Rombouts K; Marra F
Dig Dis; 2010; 28(1):229-35. PubMed ID: 20460917
[TBL] [Abstract][Full Text] [Related]
49. Pathogenesis of liver fibrosis.
Hernandez-Gea V; Friedman SL
Annu Rev Pathol; 2011; 6():425-56. PubMed ID: 21073339
[TBL] [Abstract][Full Text] [Related]
50. Involvement of epithelial-mesenchymal transition in liver fibrosis.
Yu K; Li Q; Shi G; Li N
Saudi J Gastroenterol; 2018; 24(1):5-11. PubMed ID: 29451178
[TBL] [Abstract][Full Text] [Related]
51. Reversal of liver cirrhosis: current evidence and expectations.
Jung YK; Yim HJ
Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
[TBL] [Abstract][Full Text] [Related]
52. Gene regulation in hepatic stellate cell.
Lang A; Brenner DA
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):173-9. PubMed ID: 10363203
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.
El Taghdouini A; van Grunsven LA
Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1397-1408. PubMed ID: 27762150
[TBL] [Abstract][Full Text] [Related]
54. Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P; Yee HF
Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
[TBL] [Abstract][Full Text] [Related]
55. Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis.
Zhao G; Hatting M; Nevzorova YA; Peng J; Hu W; Boekschoten MV; Roskams T; Muller M; Gassler N; Liedtke C; Davis RJ; Cubero FJ; Trautwein C
Gut; 2014 Jul; 63(7):1159-72. PubMed ID: 24037431
[TBL] [Abstract][Full Text] [Related]
56. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals.
Chen RJ; Wu HH; Wang YJ
Arch Toxicol; 2015 Oct; 89(10):1727-50. PubMed ID: 25963329
[TBL] [Abstract][Full Text] [Related]
57. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
Schattenberg JM; Nagel M; Kim YO; Kohl T; Wörns MA; Zimmermann T; Schad A; Longerich T; Schuppan D; He YW; Galle PR; Schuchmann M
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G498-506. PubMed ID: 22700824
[TBL] [Abstract][Full Text] [Related]
58. [The roles of Kupffer cells in the development and regression of liver fibrosis].
Wu JY; Liu GT
Yao Xue Xue Bao; 2008 Sep; 43(9):884-9. PubMed ID: 19048777
[TBL] [Abstract][Full Text] [Related]
59. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
Devhare PB; Sasaki R; Shrivastava S; Di Bisceglie AM; Ray R; Ray RB
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077652
[TBL] [Abstract][Full Text] [Related]
60. Hepatic stellate cells and the reversal of fibrosis.
Kisseleva T; Brenner DA
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
